3 Asian Growth Companies With High Insider Ownership

As global markets navigate a period of uncertainty, with mixed signals from economic data and shifting interest rate expectations, investors are increasingly focusing on regions like Asia for growth opportunities. In this context, companies with high insider ownership can offer an added layer of confidence, as such ownership often suggests alignment between management and shareholder interests.

Top 10 Growth Companies With High Insider Ownership In Asia

Name	Insider Ownership	Earnings Growth
Tongguan Gold Group (SEHK:340)	30.1%	29.5%
Techwing (KOSDAQ:A089030)	19.1%	64.4%
Sineng ElectricLtd (SZSE:300827)	36%	27.6%
Seers Technology (KOSDAQ:A458870)	34.1%	84.6%
Novoray (SHSE:688300)	23.6%	30.3%
Laopu Gold (SEHK:6181)	35.5%	33.9%
Gold Circuit Electronics (TWSE:2368)	31.4%	35.2%
Fulin Precision (SZSE:300432)	11.8%	50.7%
Ascentage Pharma Group International (SEHK:6855)	12.9%	91.9%
AprilBioLtd (KOSDAQ:A397030)	31%	87.1%

Click here to see the full list of 613 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc. is a biotechnology company specializing in the development of long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩25.41 trillion.

Operations: The company generates revenue primarily from its biotechnology segment, amounting to ₩158.06 billion.

Insider Ownership: 25.8%

Earnings Growth Forecast: 65.1% p.a.

Alteogen is poised for significant growth with earnings expected to rise 65.14% annually, outpacing the Korean market's average. Revenue growth is also projected to be robust at 55.4% per year. The company recently received a positive opinion from the European Medicines Agency for EYLUXVI, a biosimilar product, enhancing its market potential in Europe. Additionally, its Herceptin biosimilar has been successfully commercialized in China through Qilu Pharmaceutical collaboration.

• Take a closer look at ALTEOGEN's potential here in our earnings growth report.
• In light of our recent valuation report, it seems possible that ALTEOGEN is trading beyond its estimated value.

Meituan (SEHK:3690)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Meituan is a technology-driven retail company operating in the People's Republic of China, Hong Kong, Macao, Taiwan, and internationally with a market cap of HK$629.44 billion.

Operations: The company's revenue is derived from two main segments: Core Local Commerce, contributing CN¥264.61 billion, and New Initiatives, generating CN¥95.85 billion.

Insider Ownership: 11.2%

Earnings Growth Forecast: 31.8% p.a.

Meituan's earnings are expected to grow significantly, outpacing the Hong Kong market average. Despite slower projected revenue growth, it remains above the market rate. Recent earnings showed increased sales but a sharp decline in net income year-over-year. Meituan is expanding globally, entering Brazil with a $1 billion investment plan, though facing potential competition from Naspers' iFood. Insider trading has been minimal recently, and Naspers may sell its stake due to strategic conflicts in Latin America.

• Delve into the full analysis future growth report here for a deeper understanding of Meituan.
• Insights from our recent valuation report point to the potential undervaluation of Meituan shares in the market.

Phison Electronics (TPEX:8299)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Phison Electronics Corp. designs, manufactures, and sells flash memory controllers and peripheral system applications globally, with a market cap of NT$109.06 billion.

Operations: Phison Electronics generates revenue from its Flash Memory Control Chip Design segment, amounting to NT$58.24 billion.

Insider Ownership: 10.9%

Earnings Growth Forecast: 23.9% p.a.

Phison Electronics is poised for robust earnings growth, expected to outpace the Taiwanese market. Despite a decline in net income and profit margins, insider ownership remains high. Recent strategic partnerships with RedData and Supermicro enhance its position in AI-ready storage solutions, while collaborations like StorONE's ONEai highlight its focus on AI integration. Although revenue growth lags behind earnings projections, Phison trades at good value compared to peers and industry standards.

• Click to explore a detailed breakdown of our findings in Phison Electronics' earnings growth report.
• The analysis detailed in our Phison Electronics valuation report hints at an deflated share price compared to its estimated value.

Where To Now?

• Gain an insight into the universe of 613 Fast Growing Asian Companies With High Insider Ownership by clicking here.
• Want To Explore Some Alternatives? The end of cancer? These 29 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com